Effects of shock wave therapy to the digital ulcers of Scleroderma
Phase 3
- Conditions
- Scleroderma
- Registration Number
- JPRN-UMIN000012349
- Lead Sponsor
- Tohoku university hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
Treated with new drug for ulcer prior 4 weeks. Patients with sevear heart disease. Patients with infectious disease. The pregnant and lactating female, female who has possibility of the pregnancy. Patients who were judged inappropriate to entry this study by physician.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method